Harry and David chili mix soup is recalled

Sep 13, 2007

The U.S. Food and Drug Administration announced the nationwide recall of 1,440 bags of Harry and David Hearthside Soups, Southwestern Chicken Chili Mix.

The Harry & David Operations Corp. of Medford, Ore., said the product might contain another chili soup mix, and thus also contain a milk ingredient (whey) that isn't declared in an ingredient statement, posing a health risk for people who have an allergy or severe sensitivity to dairy products.

The recalled soups, with a 8221-1 lot code, are packaged in clear plastic 12- to 16-ounce bags that are each tied at the top with a cream-and-red ribbon. The company said the price sticker states "Fajita Chili." The product was made for Harry & David by Conifer Specialty Inc., a co-packer.

The FDA said the problem occurred when bags labeled for a previous run of Southwestern Chicken Chili Mix were inadvertently used for a subsequent run of Fajita Chili Mix, which contains a milk ingredient not declared on the Southwestern Chicken Chili Mix ingredient statement.

Consumers with questions can contact the company at 800-345-5655.

Copyright 2007 by United Press International

Explore further: AbbVie reports better-than-expected 4Q on Humira sales

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Why aren't there any human doctors in Star Wars?

7 hours ago

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.